Skip to main content
PMC home page
Applied Microbiology logoLink to Applied Microbiology
. 1972 Feb;23(2):301–308. doi: 10.1128/am.23.2.301-308.1972

Use of the Immunodiffusion Test in the Serodiagnosis of Aspergillosis

R Marie Coleman 1, Leo Kaufman 1
PMCID: PMC380335  PMID: 4622826

Abstract

The diagnostic value of an immunodiffusion (ID) test with standardized precipitinogens derived from five Aspergillus species was determined with sera from 60 proven and 12 suspected cases of aspergillosis. The data demonstrated that the greatest number of aspergillosis cases were detected by the concurrent use of A. fumigatus and A. niger precipitinogens. With these precipitinogens, the ID test permitted the serodiagnosis of aspergillosis in 82% of the 60 proven cases and in 83% of the 12 suspected cases. The presence of one or more precipitins was indicative of aspergilloma, of allergic bronchopulmonary aspergillosis, or of invasive aspergillosis. Precipitins were detected in 93% of the sera from patients with aspergilloma, in 50% of the sera from patients with allergic bronchopulmonary aspergillosis, and in 88% of the sera from patients with invasive aspergillosis. Although the presence of one or two precipitin bands could indicate any form of aspergillosis, the presence of three or four was strong evidence of either aspergilloma or invasive aspergillosis. The ID test was found to be 100% specific in an evaluation of its effectiveness with 65 sera from individuals with other systemic mycotic infections, bacterial or neoplastic diseases, and from apparently normal humans. In diagnosed cases of aspergillosis, the examination of serial serum specimens provided information about the clinical course of the disease. A reduction in the number of precipitin bands and significant titer changes were noted as the patients responded to therapy.

Full text

PDF
305

Images in this article

305Image
on p.305
305Image
on p.305
305Image
on p.305

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BROENNESTAM R., HALLBERG T. PRECIPITINS AGAINST AN ANTIGEN EXTRACT OF ASPERGILLUS FUMIGATUS IN PATIENTS WITH ASPERGILLOSIS OR OTHER PULMONARY DISEASES. Acta Med Scand. 1965 Apr;177:385–392. [PubMed] [Google Scholar]
  2. Biguet J., Fruit J., Vernes A., Capron A. La réaction de fixation du complément et l'immunoélectrophorèse appliquées au diagnostic immunologique de l'aspergillose pulmonaire. Rev Immunol (Paris) 1970 Jul-Sep;34(4):193–203. [PubMed] [Google Scholar]
  3. CAMPBELL M. J., CLAYTON Y. M. BRONCHOPULMONARY ASPERGILLOSIS. A CORRELATION OF THE CLINICAL AND LABORATORY FINDINGS IN 272 PATIENTS INVESTIGATED FOR BRONCHOPULMONARY ASPERGILLOSIS. Am Rev Respir Dis. 1964 Feb;89:186–196. doi: 10.1164/arrd.1964.89.2.186. [DOI] [PubMed] [Google Scholar]
  4. English M. P., Henderson A. H. Significance and interpretation of laboratory tests in pulmonary aspergillosis. J Clin Pathol. 1967 Nov;20(6):832–834. doi: 10.1136/jcp.20.6.832. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Halweg H., Ciszek J., Krakówka P. The reversal of serological reactions in patients with pulmonary and pleural aspergillosis after treatment. Tubercle. 1968 Dec;49(4):404–409. doi: 10.1016/s0041-3879(68)80021-2. [DOI] [PubMed] [Google Scholar]
  6. Hipp S. S., Berns D. S., Tompkins V., Buckley H. R. Latex slide agglutination test for Aspergillus antibodies. Sabouraudia. 1970 Nov;8(3):237–241. doi: 10.1080/00362177085190931. [DOI] [PubMed] [Google Scholar]
  7. LONGBOTTOM J. L., PEPYS J., CLIVE F. T. DIAGNOSTIC PRECIPITIN TEST IN ASPERGILLUS PULMONARY MYCETOMA. Lancet. 1964 Mar 14;1(7333):588–589. doi: 10.1016/s0140-6736(64)91335-2. [DOI] [PubMed] [Google Scholar]
  8. LONGBOTTOM J. L., PEPYS J. PULMONARY ASPERGILLOSIS: DIAGNOSTIC AND IMMUNOLOGICAL SIGNIFICANCE OF ANTIGENS AND C-SUBSTANCE IN ASPERGILLUS FUMIGATUS. J Pathol Bacteriol. 1964 Jul;88:141–151. doi: 10.1002/path.1700880119. [DOI] [PubMed] [Google Scholar]
  9. PEPYS J., RIDDELL R. W., CITRON K. M., CLAYTON Y. M., SHORT E. I. Clinical and immunologic significance of Aspergillus fumigatus in the sputum. Am Rev Respir Dis. 1959 Aug;80:167–180. doi: 10.1164/arrd.1959.80.2.167. [DOI] [PubMed] [Google Scholar]
  10. Parker J. D., Sarosi G. A., Doto I. L., Tosh F. E. Pulmonary aspergillosis in sanatoriums in the south central United States. A national communicable disease center cooperative mycoses study. Am Rev Respir Dis. 1970 Apr;101(4):551–557. doi: 10.1164/arrd.1970.101.4.551. [DOI] [PubMed] [Google Scholar]
  11. STALLYBRASS F. C. THE PRECIPITIN TEST IN HUMAN SYSTEMIC ASPERGILLOSIS. Mycopathol Mycol Appl. 1963 Dec 30;21:272–278. doi: 10.1007/BF02052580. [DOI] [PubMed] [Google Scholar]
  12. Slavin R. G., Million L., Cherry J. Allergic bronchopulmonary aspergillosis: characterization of antibodies and results of treatment. J Allergy. 1970 Sep;46(3):150–155. doi: 10.1016/0021-8707(70)90093-6. [DOI] [PubMed] [Google Scholar]
  13. Walter J. E., Jones R. D. Serologic tests in diagnosis of aspergillosis. Dis Chest. 1968 Jun;53(6):729–735. doi: 10.1378/chest.53.6.729. [DOI] [PubMed] [Google Scholar]

Articles from Applied Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES